本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

16.52
-0.2300-1.37%
盘后16.750.2300+1.39%16:43 EDT
成交量:88.15万
成交额:1,454.85万
市值:16.22亿
市盈率:-102.74
高:16.81
开:16.75
低:16.15
收:16.75
数据加载中...
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

SEC问询函

Form CORRESP - Correspondence
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities